MLchartDataset catalogue

Altretamine

Term · Oncology and biomedicine · MLC-T-ONC-000421

  1. An anticancer drug that belongs to the family of drugs called alkylating agents.

  2. A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity. Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage.

Table 1. Record
IdentifierMLC-T-ONC-000421
FieldOncology and biomedicine
AbbreviationHMM
Synonymshemel; hexaloids; hexamethylamine; hexamethylmelamine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-000421",
  "term": "Altretamine",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An anticancer drug that belongs to the family of drugs called alkylating agents.",
    "A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity. Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage."
  ],
  "abbreviation": "HMM",
  "synonyms": [
    "hemel",
    "hexaloids",
    "hexamethylamine",
    "hexamethylmelamine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/altretamine/"
}

Record 910 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.